Show simple item record

dc.contributor.authorWorld Health Assembly, 2
dc.coverage.spatialGenevaen
dc.date.accessioned2014-01-09T08:53:59Z
dc.date.available2014-01-09T08:53:59Z
dc.date.issued1949
dc.identifier.govdocA2/24
dc.identifier.urihttp://www.who.int/iris/handle/10665/98724
dc.description(‎Provisional agenda item 8.16.1.1)‎en
dc.descriptionWHO/BS/70en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshReference Standardsen
dc.subject.meshVaccinesen
dc.subject.meshHormonesen
dc.subject.meshVitaminsen
dc.subject.meshAnti-Bacterial Agentsen
dc.subject.meshBlood Group Antigensen
dc.titleReport on the third session of the Expert Committee on Biological Standardizationen
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • WHA2
    18 June - 2 July 1949

Show simple item record